We regard the protection of our intellectual property to be critical to the success of our business and accordingly, we actively seek patent protection for our intellectual property. Chemokine currently has 11 issued patents and 16 pending patents

A selection of key patents is available to the public by visiting the website of the United States Patent and Trademark Office.

• 1. Therapeutics for chemokine mediated diseases
• 2. CXCR4 antagonist treatment of hematopoeitic cells
• 3. Bicyclic aromatic chemokine receptor ligands
• 4. Therapeutic chemokine receptor antagonists
• 5. Cyclic peptides for modulating growth of neovessels and their use in therapeutics angiogenesis
• 6. Novel chemokine mimetics synthesis and their use
• 7. Design of chemokine analogs for treatment of human diseases
• 8. Tricyclic terpenes of the family of abietic acid as rantes inhibitor
• 9. Mimetics of Interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease
• 10. Design of CXC chemokine analogs for the treatment of human diseases
• 11. Platelet Factor-4 (PF-4) analogs and their use